Lovely Professional University Plans Pharmaceutical Research Commercialization with Synkrom Health-Care Ltd.

Pulsing the emerging role of academia in commercializing innovation, Lovely Professional University has signed an MOU with Synkrom Healthcare Pvt. Ltd. for its School of Pharmacy in regard to Pharmaceutical Research Commercialization. The School will provide the company the commercially viable Research oriented products to be manufactured as market drugs. In this regard, at first instance, the Company will Get International Patent for ‘Joshanda Lozenges’ researched and developed out of traditional poly-herbal mixture Joshanda by the Pharmaceutical Department of LPU.

Under this MOU, from now onwards LPU and Synkrom are going to constantly strive to create a harmonious environment for manufacture of products that are innovative, better than existing ones and affordable in all respects. This is likely to reduce the internal cost of producing new medicines.

At this, Dr. Monica Gulati, Dean, School of Applied Medical Sciences of LPU expressed: “It will be very satisfying for a researcher to see a product coming out of a thesis. However, a lack of industrial collaboration always resulted in keeping the best of theses untapped and unused lying waste on the shelves only.” Dr. Gulati further added: “Joshanda, a poly-herbal mixture, did not enjoy worldwide popularity as it involves cumbersome boiling process. We worked and converted the mixture into cough drops as ‘Joshanda lozenges’ having a long lasting soothing effect with remarkable inhibitory activity on the bacteria. These ‘lozenges’ act as effective drug against other prescribed cough suppressants and also with no side effects.”

On the similar grounds, committed to convert innovative technologies into marketable products; The Managing Director, Satyakam Rahul of ‘Synkrom’ is of the opinion: “ I feel that there is no dearth of refined talent within the country itself. However, systems to nurture innovative developments are lacking. The most of the pharmaceutical companies are focussed on ‘generic drugs’ rather than promoting innovations. So, recognizing an immediate need for a ‘Development Support’ to an ‘Academic Research’, we have founded a ‘Development Company’ exclusively for nurturing of innovations.” Further confirming the company would manufacture ‘lozenges’, he said: “Our department has done its job at the research level. We have signed an agreement and will evaluate the data, after which it will be filed for an international patent. Later, we will also take approval from the Food and Drug Authority.” Parikshit Bansal, in charge of the Intellectual Property Rights Cell at the National Institute of Education and Research, Mohali, said, “Research should not just be restricted to labs. If ‘Lozenges’are found commercially viable, such a research should be turned into a market drug.”

On this occasion, the Chancellor of the University, Sh. Ashok Mittal said: “Research commercialization is the key to progress and development of the nation, so it must be encouraged. It was one of my dreams that Research-Work from our University should lead to innovative Healthcare products economically benefitting all those sufferers who remain in dire need of these. This MOU has started to materialize this dream into a great humane reality. In-fact, Research organizations are becoming increasingly adept at developing own venture arms to finance commercial development of discoveries. LPU has also chosen to be on the path of being an economic engine in this regard. As appetites of educational institutions for commercializing research grow, these should apply their technologies and programmes to more goal-oriented research to become perfect Goal-oriented academia.”